InvestorsHub Logo

IgnoranceIsBliss

12/28/19 7:40 AM

#237488 RE: sharinky #237487

It’s either of those claims on ALL of the patents in question — they need to kill them all with one of the two claims.

Pharmacydude

12/28/19 7:44 AM

#237489 RE: sharinky #237487

Sharinky
If Dr Reddy’s wins on their claim they are not infringing by selling to pts for less then 12 weeks then generic V becomes available and pts regardless of indication will get the least expensive equivalent molecule which will be a generic V and Amarin loses almost all its US revenue.

If Dr Reddy wins their claim that the IP was obvious and therefore the patents are invalid then generic V can be sold and Amarin loses almost all its US revenue.

They only have to be successful with 1 claim to win the entire US market.